Birgit Stattin Norinder
Board of Director
pharmaceutical
Hansa Medical
Sweden
Biography
Birgit has extensive experience from international pharmaceutical and biotechnology companies in Sweden, the USA and the United Kingdom. She has managed several research and development departments, resulting in a number of novel and approved pharmaceuticals. Amongst many things she has served as CEO and Chairman at Prolifix Ltd., Senior VP Worldwide Product Development, Pharmacia & Upjohn and Dir. Int. Reg. Affairs Division, Glaxo Group Research Ltd. Birgit has also held several board and chairman positions of U.K., Swedish and Norwegian biotechnology companies. Birgit is also director of the board at Jettesta AB, Nicox S.A. and AddLife AB. Chairman of the Board of Hansa Medical 2014-2016. Birgit holds an M.Sc. in Pharmacy from Uppsala University. Born 1948. Birgit is Chairman of Hansa Medical´s Remuneration Committee, and member of the Audit Committee and Scientific CommitteeIndependent of Hansa Medical and its senior management.Independent of major shareholders of Hansa Medical.
Research Interest
Pharmaceutical Product Development,Research and Developmentin Biotechnology
